Stanka Lotric-Furlan

Stanka Lotric-Furlan

Auto-generated profile, based on publicly available information

Stanka Lotric-Furlan

Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525 Ljubljana, Slovenia

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
SLStanka Lotrič-Furlan
Stanka Lotrič-Furlan
TRTereza Rojko
Tereza Rojko
MPMiroslav Petrovec
Miroslav Petrovec
TATatjana Avsic-Zupanc
Tatjana Avsic-Zupanc
FSFranc Strle
Franc Strle

Verified
Journal Article
Open access
PDF file
PBPetra Bogovič
Petra Bogovič
LLLara Lusa
Lara Lusa
MKMisa Korva
Misa Korva
MPMiša Pavletič
Miša Pavletič
KRKatarina Resman Rus
Katarina Resman Rus
FSFranc Strle
Franc Strle
Clinical manifestations of tick-borne encephalitis (TBE) are thought to result from the host immune responses to infection, but knowledge of such responses is incomplete. We performed a detailed clinical evaluation and characterization of innate and adaptive inflammatory immune responses in matched serum and cerebrospinal fluid (CSF) samples from 81 adult patients with TBE. Immune responses were then correlated with laboratory and clinical findings. The inflammatory immune responses were generally site-specific. Cytokines and chemokines associated with innate and Th1 adaptive immune responses were significantly higher in CSF, while mediators associated with Th17 and B-cell responses were generally higher in serum. Furthermore, mediators associated with innate and Th1 adaptive immune responses were positively associated with disease severity, whereas Th17 and B cell immune responses were not. During the meningoencephalitic phase of TBE, innate and Th1 adaptive inflammatory mediators were highly concentrated in CSF, the site of the disease. The consequence of this robust immune response was more severe acute illness. In contrast, inflammatory mediators associated with B cell and particularly Th17 responses were concentrated in serum. These findings provide new insights into the immunopathogenesis of TBE and implicate innate and Th1 adaptive responses in severity and clinical presentation of acute illness.

15 August 2001 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SLStanka Lotrič‐Furlan
Stanka Lotrič‐Furlan
MPMiroslav Petrovec
Miroslav Petrovec
TATatjana Avsic-Zupanc
Tatjana Avsic-Zupanc
WNWilliam L. Nicholson
William L. Nicholson
JSJohn W. Sumner
John W. Sumner
FSFranc Strle
Franc Strle
A prospective study established the etiology of febrile illnesses in residents of Slovenia that occurred within 6 weeks after a tick bite. A combinat

31 July 2002
Verified
Journal Article
Closed access
Eva Ružić-SabljićEva Ružić-Sabljić
Eva Ružić-Sabljić
VMVera Maraspin
Vera Maraspin
SLStanka Lotric-Furlan
Stanka Lotric-Furlan
TJTomaz Jurca
Tomaz Jurca
MLMateja Logar
Mateja Logar
FSFranc Strle
Franc Strle

1 September 2001 in Clinical and Diagnostic Laboratory Immunology
Verified
Journal Article
Open access
PDF file
SLStanka Lotrič-Furlan
Stanka Lotrič-Furlan
TATatjana Avsic-Zupanc
Tatjana Avsic-Zupanc
MPM. Petrovec
M. Petrovec
WNW. L. Nicholson
W. L. Nicholson
JSJ. W. Sumner
J. W. Sumner
FSF. Strle
F. Strle
An evaluation of the clinical outcome and the duration of the antibody response of patients with human granulocytic ehrlichiosis (HGE) was undertaken in Slovenia. Adult patients with a febrile illness occurring within 6 weeks of a tick bite were classified as having probable or confirmed HGE based on the outcome of serological or PCR testing. Thirty patients (median age, 44 years) were enrolled, and clinical evaluations and serum collection were undertaken at initial presentation and at 14 days, 6 to 8 weeks, and 3 to 4, 6, 12, 18, and 24 months. An indirect immunofluorescence assay (IFA) was performed, and reciprocal titers of ≥128 were interpreted as positive. Patients presented a median of 4 days after the onset of fever and were febrile for a median of 7.5 days; four (13.3%) received doxycycline. Seroconversion was observed in 3 of 30 (10.0%) patients, and 25 (83.3%) showed >4-fold change in antibody titer. PCR results were positive in 2 of 3 (66.7%) seronegative patients but in none of 27 seropositive patients at the first presentation. IFA antibody titers of ≥128 were found in 14 of 29 (48.3%), 17 of 30 (56.7%), 13 of 30 (43.4%), and 12 of 30 (40.0%) patients 6, 12, 18, and 24 months after presentation, respectively. Patients reporting additional tick bites during the study had significantly higher antibody titers at most time points during follow-up. No long-term clinical consequences were found during follow-up.

31 October 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
PBPetra Bogovič
Petra Bogovič
LLLara Lusa
Lara Lusa
MKMisa Korva
Misa Korva
SLStanka Lotrič-Furlan
Stanka Lotrič-Furlan
KRKatarina Resman Rus
Katarina Resman Rus
FSFranc Strle
Franc Strle
Information on the association of inflammatory immune responses and disease outcome after tick-borne encephalitis (TBE) is limited. In the present study, we assessed the levels of 24 cytokines/chemokines associated with innate and adaptive immune responses in matched serum and cerebrospinal fluid (CSF) samples of 81 patients at first visit, and in serum at follow-up time points. Serum levels of several cytokines/chemokines obtained during the meningoencephalitic phase of TBE differed compared to the levels at a follow-up visit 2 months later; several significant differences were also found in cytokine/chemokine levels in serum at 2 months compared to the last time point, 2–7 years after acute illness. Cytokines/chemokines levels in CSF or serum obtained at the time of acute illness or serum levels obtained 2 months after the onset of TBE did not have predictive value for an unfavorable outcome 2–7 years later. In contrast, serum levels of mediators associated with Th17 responses were lower in patients with unfavorable outcome whereas those associated with other adaptive or innate immune responses were higher at the last visit in those with an unfavorable outcome. These findings provide new insights into the immunopathogenesis of TBE and implicate inflammatory immune responses with post-encephalitic syndrome years after the initial infection.